Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to ...

Clinical pharmacoeconomics lead says one million people could benefit from weight loss drugs, but cost would be ‘unaffordable ...

Curbs will have to be put on which patients are to be eligible for weight loss jabs Mounjaro and Wegovy when they are added ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

These are referred to as compounded drugs, which, while containing some of the same ingredients, are not identical to the ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

They also include Saxenda and Wegovy, which the FDA approved for weight loss for people with at least one weight-related health comorbidity. The researchers looked at how U.S. spending on the ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...